Vitalhub Valuation

Is VHI undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of VHI when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: VHI (CA$11.29) is trading below our estimate of fair value (CA$34.25)

Significantly Below Fair Value: VHI is trading below fair value by more than 20%.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for VHI?

Key metric: As VHI is barely profitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for VHI. This is calculated by dividing VHI's market cap by their current revenue.
What is VHI's PS Ratio?
PS Ratio9.6x
SalesCA$61.61m
Market CapCA$592.53m

Price to Sales Ratio vs Peers

How does VHI's PS Ratio compare to its peers?

The above table shows the PS ratio for VHI vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average6.2x
KSI kneat.com
12x28.5%CA$538.3m
RHT Reliq Health Technologies
3.2xn/aCA$47.3m
NURS Hydreight Technologies
3.2xn/aCA$50.0m
CDX.H Cloud DX
6.2xn/aCA$12.1m
VHI Vitalhub
9.6x19.8%CA$592.5m

Price-To-Sales vs Peers: VHI is expensive based on its Price-To-Sales Ratio (9.6x) compared to the peer average (6.2x).


Price to Sales Ratio vs Industry

How does VHI's PS Ratio compare vs other companies in the CA Healthcare Services Industry?

7 CompaniesPrice / SalesEstimated GrowthMarket Cap
THNK Think Research
0.3x6.5%US$17.84m
KOVO Kovo+ Holdings
0.4xn/aUS$3.80m
CRBK Carebook Technologies
0.3xn/aUS$3.30m
CBP Certive Solutions
1xn/aUS$1.27m
VHI 9.6xIndustry Avg. 2.8xNo. of Companies7PS048121620+
7 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: VHI is expensive based on its Price-To-Sales Ratio (9.6x) compared to the North American Healthcare Services industry average (2.8x).


Price to Sales Ratio vs Fair Ratio

What is VHI's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

VHI PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio9.6x
Fair PS Ratio7.3x

Price-To-Sales vs Fair Ratio: VHI is expensive based on its Price-To-Sales Ratio (9.6x) compared to the estimated Fair Price-To-Sales Ratio (7.3x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst VHI forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentCA$11.29
CA$13.29
+17.7%
8.7%CA$15.00CA$12.00n/a7
Nov ’25CA$10.25
CA$10.96
+6.9%
9.9%CA$13.00CA$10.00n/a6
Oct ’25CA$8.50
CA$9.83
+15.7%
4.8%CA$10.50CA$9.00n/a6
Sep ’25CA$8.02
CA$9.67
+20.5%
3.9%CA$10.00CA$9.00n/a6
Aug ’25CA$8.10
CA$8.25
+1.9%
5.8%CA$8.75CA$7.50n/a6
Jul ’25CA$7.42
CA$8.08
+8.9%
5.3%CA$8.75CA$7.50n/a6
Jun ’25CA$6.88
CA$7.88
+14.5%
4.4%CA$8.50CA$7.50n/a6
May ’25CA$6.37
CA$7.71
+21.0%
4.7%CA$8.50CA$7.50n/a6
Apr ’25CA$6.00
CA$7.54
+25.7%
7.8%CA$8.50CA$6.75n/a6
Mar ’25CA$5.77
CA$6.38
+10.5%
8.1%CA$7.00CA$5.50n/a6
Feb ’25CA$4.55
CA$5.46
+20.0%
10.0%CA$6.00CA$4.50n/a6
Jan ’25CA$4.08
CA$5.46
+33.8%
10.0%CA$6.00CA$4.50n/a6
Dec ’24CA$4.31
CA$5.33
+23.7%
10.4%CA$6.00CA$4.50CA$11.296
Nov ’24CA$2.85
CA$5.13
+79.8%
10.4%CA$6.00CA$4.25CA$10.256
Oct ’24CA$2.95
CA$5.13
+73.7%
10.4%CA$6.00CA$4.25CA$8.506
Sep ’24CA$2.77
CA$5.13
+85.0%
10.4%CA$6.00CA$4.25CA$8.026
Aug ’24CA$2.49
CA$4.92
+97.5%
11.2%CA$6.00CA$4.25CA$8.106
Jul ’24CA$2.56
CA$4.92
+92.1%
11.2%CA$6.00CA$4.25CA$7.426
Jun ’24CA$2.70
CA$4.92
+82.1%
11.2%CA$6.00CA$4.25CA$6.886
May ’24CA$2.68
CA$4.92
+83.5%
11.2%CA$6.00CA$4.25CA$6.376
Apr ’24CA$2.54
CA$4.92
+93.6%
11.2%CA$6.00CA$4.25CA$6.006
Mar ’24CA$2.63
CA$4.96
+88.5%
11.1%CA$6.00CA$4.25CA$5.776
Feb ’24CA$2.88
CA$4.96
+72.2%
11.1%CA$6.00CA$4.25CA$4.556
Jan ’24CA$2.65
CA$4.96
+87.1%
11.1%CA$6.00CA$4.25CA$4.086
Dec ’23CA$2.26
CA$4.75
+110.2%
6.7%CA$5.00CA$4.25CA$4.315

Analyst Forecast: Target price is less than 20% higher than the current share price.


Discover undervalued companies